Filing Details
- Accession Number:
- 0001209191-22-056364
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-10 16:04:58
- Reporting Period:
- 2022-11-09
- Accepted Time:
- 2022-11-10 16:04:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1831828 | Vera Therapeutics Inc. | VERA | Pharmaceutical Preparations (2834) | 812744449 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1857670 | Joanne Curley | C/O Vera Therapeutics, Inc. 8000 Marina Boulevard, Suite 120 Brisbane CA 94005 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2022-11-09 | 494 | $16.54 | 27,315 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 13, 2022.
Billionaire Hedge Funds
